FDA moves to rehire medical device, food safety and other staffers fired days earlier
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news ...
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
Pfizer hires ex-FDA drug chief as top doctor
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...
FDA scrambles to rehire food safety and other staffers who were fired last week
The Trump administration's chaotic cost-cutting has let to similar reversals at other agencies, which sought to rehire ex-employees responsible for nuclear weapons, national parks and other government ...
Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The US Food and Drug Administration’s new standards for foods to meet before they can be labeled as “healthy” on their ...
STAT3h
Patrizia Cavazzoni, former head of FDA’s drug center, joins Pfizer as chief medical officer
Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.
Pfizer Names Former FDA Drug Chief as Top Doctor
Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.